Skip to main content
Cattle Healthcare Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, France, Germany, India, China - Size and Forecast 2024-2028

Cattle Healthcare Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, France, Germany, India, China - Size and Forecast 2024-2028

Published: Feb 2024 169 Pages SKU: IRTNTR77493

Market Overview at a Glance

$4.47 B
Market Opportunity
8.91%
CAGR
7.53
YoY growth 2023-2024(%)

Cattle Healthcare Market Size 2024-2028

The cattle healthcare market size is forecast to increase by USD 4.47 billion at a CAGR of 8.91% between 2023 and 2028.

  • The market is experiencing significant growth due to several key factors. The increasing burden of cattle diseases is a major driver for market expansion, as farmers seek effective solutions to maintaIn the health and productivity of their herds. Additionally, the rising shift towards animal farming, particularly in developing countries, is creating new opportunities for market participants. However, challenges remain In the form of problematic disease management practices, which necessitate the development of advanced healthcare solutions. These trends and growth factors are shaping the future of the market, offering potential for innovation and growth.

    • What will be the Size of the Cattle Healthcare Market During the Forecast Period?

    Cattle Healthcare Market Size

     Request Free Sample

  • The market encompasses a range of products and services aimed at maintaining the health and productivity of bovine livestock. Animal husbandry practices prioritize preventative measures against diseases such as bovine tuberculosis, anthrax, brucellosis, rabies, milk fever, and chronic conditions like mastitis and inflammation of the mammary gland. Clinical mastitis, a common ailment causing inflammation and infection In the mammary gland, significantly impacts milk production and necessitates timely intervention. Drug consumption and medical devices are integral components of cattle healthcare, with a focus on enhancing immunity and mitigating the spread of diseases. The adoption of advanced technologies, including vaccine development, is driving market revenues in this sector.
  • The market is a critical aspect of livestock production, with implications for both milk and meat production industries, as well as poultry production.

    • How is this Cattle Healthcare Industry segmented and which is the largest segment?

    The cattle healthcare industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

    • Type
      • Beef cattle
      • Dairy cattle
    • Product
      • Pharmaceuticals
      • Feed additives
      • Vaccines
      • Others
    • Geography
      • North America
        • US
      • Europe
        • Germany
        • France
      • Asia
        • China
        • India
      • Rest of World (ROW)

      By Type Insights

      • The beef cattle segment is estimated to witness significant growth during the forecast period.

      Beef cattle healthcare is a critical component of animal farming, focusing on the prevention, diagnosis, and treatment of diseases, as well as the promotion of productivity and animal welfare. Disease prevention is achieved through vaccination programs targeting illnesses like bovine tuberculosis, milk fever, and chronic diseases, ensuring herd health and reducing drug consumption. Proper nutrition plays a significant role in maintaining cattle health and productivity, with balanced diets tailored to various life stages. Regular health monitoring, including parasite control and hoof care, is essential to address potential health issues. Medical devices, such as diagnostic imaging tools like CT scans and magnetic resonance imaging, are used to diagnose and treat conditions affecting the mammary gland, such as clinical mastitis and inflammation.

      Veterinary services and medications, including vaccines and medicines naturally derived, are crucial in maintaining the well-being of the cattle population. Livestock production, including milk production, poultry production, and dairy industry, relies on effective cattle healthcare practices, with emerging economies investing in initiatives to improve infrastructure, funding, and awareness. Disease control and monitoring are essential for sustainable livestock production, addressing zoonotic diseases like Salmonellosis and ensuring animal welfare.

      Cattle Healthcare Market Size

      Get a glance at the  Cattle Healthcare Industry report of share of various segments Request Free Sample

      The Beef cattle segment was valued at USD 3.7 billion in 2018 and showed a gradual increase during the forecast period.

      Regional Analysis

      • North America is estimated to contribute 37% to the growth of the global market during the forecast period.

      Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

      Cattle Healthcare Market Share by Geography

      For more insights on the market share of various regions, Request Free Sample

      The North American the market is experiencing significant growth due to several factors. The region's increasing cattle population and heightened focus on animal welfare have fueled the demand for advanced cattle healthcare solutions. Approximately 60% to 65% of US households own cattle, with around 85 million to 87 million homes housing them. To enhance cattle health, veterinary clinics and hospitals are adopting innovative healthcare products and services. Chronic diseases in aging cattle contribute to market expansion. For instance, the North American Veterinary Community (NAVC) regularly highlights the latest advancements in pain treatment, driving industry growth through knowledge sharing. Cattle health encompasses various aspects, including immunity, mastitis, inflammation, and disease prevention.

      Effective management practices, veterinary care, medications, vaccination programs, parasite control, nutritional management, disease surveillance, and animal welfare are essential components of the market. Additionally, initiatives from public and private organizations, diagnostic imaging technologies like CT scans and magnetic resonance imaging, and veterinary services are crucial in maintaining the physical and mental well-being of cattle. Disease prevention, nutrition, environment, and disease control are integral to sustainable livestock production, which is a critical sector for animal protein supply and population growth. Zoonotic diseases, such as bovine tuberculosis, milk fever, lumpy skin disease, and Salmonellosis, pose significant challenges to the market. Awareness and regulations regarding ethical use, veterinary drugs, vaccines, and medicines naturally align with the dairy industry's needs in emerging economies.

      Environmental concerns and sustainable production practices are essential considerations for the livestock industry's future. Vaccination campaigns and regulations are crucial in ensuring herd health and animal welfare.

      Market Dynamics

      Our  researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

      What are the key market drivers leading to the rise In the adoption of Cattle Healthcare Industry?

      Rising burden of cattle diseases is the key driver of the market.

    • The market is experiencing significant growth due to the increasing burden of diseases affecting cattle. Animal husbandry, a critical component of animal farming, requires continuous efforts to maintaIn the health and productivity of cattle. Cattle are susceptible to various diseases such as bovine tuberculosis, milk fever, chronic diseases, and mastitis, which can lead to inflammation of the mammary gland, clinical mastitis, and increased drug consumption. These diseases not only impact the physical health of the animals but also have economic implications, including reduced milk production, increased mortality rates, and higher treatment costs. The expanding livestock production, including milk and poultry production, necessitates effective disease prevention, diagnosing, and treating methods.
    • Vaccine development for diseases like lumpy skin disease and initiatives from public and private organizations are crucial in addressing the disease burden. Infrastructure development, funding, and veterinary services, including diagnostic imaging techniques such as CT scans and magnetic resonance imaging, play a vital role in enhancing cattle health. The growing demand for animal products due to population growth and the dairy industry's expansion in emerging economies necessitates sustainable production practices. Preventive measures like parasite control, nutritional management, disease surveillance, and animal welfare are essential for herd health and management practices. Veterinary care, medications, and vaccination programs are crucial in maintaining the well-being of cattle and ensuring disease control and monitoring.
    • Environmental concerns and ethical use of veterinary drugs and vaccines are essential considerations In the market. Regulations and awareness campaigns are crucial in ensuring the ethical use of veterinary drugs, vaccines, and medications while addressing the economic implications of disease outbreaks. Sustainability and ethical practices are essential in maintaining the livestock industry's long-term viability and ensuring the production of high-quality animal protein. Zoonotic diseases like salmonellosis pose a significant threat to both animal and human health. Ensuring disease prevention and monitoring practices are essential in maintaining herd health and protecting public health. Overall, the market's growth is driven by the need to maintaIn the health and productivity of cattle while ensuring sustainable and ethical practices in animal farming.

      • What are the market trends shaping the Cattle Healthcare Industry?

      Rising shift towards animal farming is the upcoming market trend.

    • The market is experiencing significant growth due to the expanding animal farming industry and the increasing demand for livestock products, particularly in emerging economies. The rising population and the resulting need for protein-rich foods have created a vast market for beef and dairy, providing opportunities for cattle farmers to increase production. Advanced technologies, such as precision agriculture, genetic engineering, and digital monitoring systems, are transforming cattle farming by improving productivity and efficiency. Another critical factor driving the market is the prevalence of diseases in cattle, including bovine tuberculosis, milk fever, chronic diseases, mastitis, and inflammation. These conditions can significantly impact the health and well-being of the animals, leading to decreased milk production, increased drug consumption, and reduced herd health.
    • To address these challenges, the market for cattle healthcare products and services is witnessing a surge in investment in vaccine development, medical devices, and veterinary services. Moreover, initiatives from public and private organizations are playing a crucial role in disease prevention, diagnosis, and treatment. These initiatives include infrastructure development, funding for research, animal testing, and awareness campaigns. The focus on animal welfare, sustainability, and disease control is also driving the adoption of nutritional management, parasite control, and monitoring and evaluation practices. In conclusion, the market is experiencing significant growth due to the expanding animal farming industry, increasing demand for livestock products, and the prevalence of diseases in cattle.
    • Technological advancements, investment in research and development, and initiatives from public and private organizations are key drivers of market growth. The market encompasses various aspects, including physical and mental health, disease prevention, nutrition, environment, and disease surveillance, all aimed at ensuring the well-being of cattle and the sustainability of the livestock industry.

      • What challenges does the Cattle Healthcare Industry face during its growth?

      Problem in disease management of cattle is a key challenge affecting the industry growth.

    • The market faces a substantial hurdle due to the management of diseases in cattle. Cattle are prone to various infectious and non-infectious diseases, which can negatively impact herd health, productivity, and revenue. Disease outbreaks lead to significant economic losses for farmers through decreased milk production, reduced weight gain, and increased mortality rates. Moreover, they incur additional expenses on veterinary treatments and disease control measures. Preventing and controlling infectious diseases is a primary challenge due to the high-density environments in which cattle are often raised, such as feedlots and intensive farming operations, which can facilitate the transmission of infectious pathogens.
    • Chronic diseases, including bovine tuberculosis, milk fever, and mastitis, are common in cattle and can lead to inflammation of the mammary gland, resulting in clinical mastitis. Disease prevention initiatives by public and private organizations, including vaccine development for diseases like lumpy skin disease, are essential to mitigate the impact of diseases on cattle health and productivity. Nutritional management, parasite control, and disease surveillance are crucial components of herd health management practices. Veterinary care, medications, and vaccination programs are essential in treating and preventing diseases. Immunity, mental and physical well-being, and animal welfare are vital aspects of sustainable livestock production, including milk production In the dairy industry and livestock production for animal protein in emerging economies.
    • Environmental concerns and regulations play a significant role in ethical use of veterinary drugs, vaccines, and medicines In the livestock industry. Disease control and monitoring are essential to ensure the health and safety of the animal population and the human population from zoonotic diseases, such as Salmonellosis.

      • Exclusive Customer Landscape

      The cattle healthcare market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the cattle healthcare market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

      Cattle Healthcare Market Share by Geography

       Customer Landscape

      Key Companies & Market Insights

      Companies are implementing various strategies, such as strategic alliances, cattle healthcare market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

      Biozyme Inc. - The company specializes in providing a range of healthcare solutions for the cattle industry. Among its offerings are AO Biotics Amaferm, AO Biotics EQE, and VitaFerm products. These solutions are designed to enhance cattle health and productivity through nutritional supplementation and microbial balancing. AO Biotics Amaferm is a prebiotic that promotes a healthy digestive system, while AO Biotics EQE is an ionophore that improves feed efficiency and growth. VitaFerm, on the other hand, is a mineral supplement that provides essential nutrients for optimal health and performance. By offering these innovative solutions, the company aims to help cattle producers improve herd health and profitability.

      The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

      • Biozyme Inc.
      • Boehringer Ingelheim International GmbH
      • Ceva Sante Animale
      • Elanco Animal Health Inc.
      • IDEXX Laboratories Inc.
      • ImmuCell Corp.
      • Indian Immunologicals Ltd.
      • Innovative Diagnostics
      • International Health Care Ltd.
      • Kyoritsuseiyaku Corp.
      • Merck and Co. Inc.
      • Norbrook Laboratories Ltd.
      • Phibro Animal Health Corp.
      • Thermo Fisher Scientific Inc.
      • Vamso Biotec Pvt. Ltd.
      • Vetoquinol SA
      • Virbac Group
      • Zenex Animal Health India Private Ltd.
      • Zoetis Inc.
      • Zovix Pharmaceuticals

      Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

      Research Analyst Overview

      Cattle healthcare is a crucial aspect of animal husbandry and livestock production, focusing on maintaining the physical and mental well-being of bovine animals. The importance of cattle health lies in enhancing productivity, ensuring the quality of animal products, and promoting sustainable livestock industry practices. Chronic diseases, such as bovine tuberculosis and mastitis, pose significant challenges to the industry. These conditions can lead to substantial drug consumption and veterinary care expenses, impacting the profitability of livestock farms. In addition, diseases like milk fever and inflammation of the mammary gland can negatively affect milk production, further reducing the overall efficiency of the operation.

      To address these challenges, various initiatives have been undertaken to improve cattle health through vaccine development, infrastructure development, and funding for research and development. Veterinary services play a vital role in diagnosing and treating clinical mastitis and other diseases, while diagnostic imaging technologies like CT scans and magnetic resonance imaging help in identifying and monitoring health issues. Preventive measures, such as disease surveillance, parasite control, and nutritional management, are essential for maintaining herd health. Proper management practices, including monitoring and evaluation, are crucial in ensuring the well-being of cattle. Public and private organizations have taken various initiatives to promote disease prevention and control In the livestock industry.

      These initiatives include vaccination programs, regulations, and ethical use of veterinary drugs and vaccines. Awareness campaigns have also been launched to educate farmers about the importance of animal welfare and sustainable production practices. The dairy industry, in particular, has been a significant focus of these efforts due to its high production volume and the potential for zoonotic diseases, such as salmonellosis, to spread from cattle to humans. Emerging economies are also investing in improving their livestock production systems to meet the growing demand for animal protein and address population growth. Environmental concerns have become increasingly important In the livestock industry, with a focus on sustainable production practices.

      This includes reducing the use of antibiotics and promoting disease prevention through better infrastructure, nutrition, and management practices. In conclusion, the market is a dynamic and evolving industry focused on maintaining the health and well-being of bovine animals. Through various initiatives, including vaccine development, veterinary services, and preventive measures, the industry is working to improve productivity, ensure the quality of animal products, and promote sustainable livestock production practices.

      Market Scope

      Report Coverage

      Details

      Page number

      169

      Base year

      2023

      Historic period

      		 2018-2022

      Forecast period

      2024-2028

      Growth momentum & CAGR

      Accelerate at a CAGR of 8.91%

      Market growth 2024-2028

      USD 4473.02 million

      Market structure

      Fragmented

      YoY growth 2023-2024(%)

      7.53

      Key countries

      US, France, Germany, India, and China

      Competitive landscape

      Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

      Request Free Sample

      What are the Key Data Covered in this Cattle Healthcare Market Research and Growth Report?

      • CAGR of the Cattle Healthcare industry during the forecast period
      • Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
      • Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
      • Accurate predictions about upcoming growth and trends and changes in consumer behaviour
      • Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
      • Thorough analysis of the market’s competitive landscape and detailed information about companies
      • Comprehensive analysis of factors that will challenge the cattle healthcare market growth of industry companies

      We can help! Our analysts can customize this cattle healthcare market research report to meet your requirements.

      Get in touch

       

      1 Executive Summary

      • 1.1 Market overview
        • Exhibit 01: Executive Summary – Chart on Market Overview
        • Exhibit 02: Executive Summary – Data Table on Market Overview
        • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
        • Exhibit 04: Executive Summary – Chart on Market by Geography
        • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
        • Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
        • Exhibit 07: Executive Summary – Chart on Incremental Growth
        • Exhibit 08: Executive Summary – Data Table on Incremental Growth
        • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

      2 Market Landscape

      • 2.1 Market ecosystem
        • Exhibit 10: Parent market
        • Exhibit 11: Market Characteristics

      3 Market Sizing

      • 3.1 Market definition
        • Exhibit 12: Offerings of vendors included in the market definition
      • 3.2 Market segment analysis
        • Exhibit 13: Market segments
      • 3.3 Market size 2023
        • 3.4 Market outlook: Forecast for 2023-2028
          • Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
          • Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
          • Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
          • Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

        4 Historic Market Size

        • 4.1 Global cattle healthcare market 2018 - 2022
          • Exhibit 18: Historic Market Size – Data Table on global cattle healthcare market 2018 - 2022 ($ million)
        • 4.2 Type Segment Analysis 2018 - 2022
          • Exhibit 19: Historic Market Size – Type Segment 2018 - 2022 ($ million)
        • 4.3 Products Segment Analysis 2018 - 2022
          • Exhibit 20: Historic Market Size – Products Segment 2018 - 2022 ($ million)
        • 4.4 Geography Segment Analysis 2018 - 2022
          • Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)
        • 4.5 Country Segment Analysis 2018 - 2022
          • Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

        5 Five Forces Analysis

        • 5.1 Five forces summary
          • Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
        • 5.2 Bargaining power of buyers
          • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
        • 5.3 Bargaining power of suppliers
          • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
        • 5.4 Threat of new entrants
          • Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
        • 5.5 Threat of substitutes
          • Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
        • 5.6 Threat of rivalry
          • Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
        • 5.7 Market condition
          • Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

        6 Market Segmentation by Type

        • 6.1 Market segments
          • Exhibit 30: Chart on Type - Market share 2023-2028 (%)
          • Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
        • 6.2 Comparison by Type
          • Exhibit 32: Chart on Comparison by Type
          • Exhibit 33: Data Table on Comparison by Type
        • 6.3 Beef cattle - Market size and forecast 2023-2028
          • Exhibit 34: Chart on Beef cattle - Market size and forecast 2023-2028 ($ million)
          • Exhibit 35: Data Table on Beef cattle - Market size and forecast 2023-2028 ($ million)
          • Exhibit 36: Chart on Beef cattle - Year-over-year growth 2023-2028 (%)
          • Exhibit 37: Data Table on Beef cattle - Year-over-year growth 2023-2028 (%)
        • 6.4 Dairy cattle - Market size and forecast 2023-2028
          • Exhibit 38: Chart on Dairy cattle - Market size and forecast 2023-2028 ($ million)
          • Exhibit 39: Data Table on Dairy cattle - Market size and forecast 2023-2028 ($ million)
          • Exhibit 40: Chart on Dairy cattle - Year-over-year growth 2023-2028 (%)
          • Exhibit 41: Data Table on Dairy cattle - Year-over-year growth 2023-2028 (%)
        • 6.5 Market opportunity by Type
          • Exhibit 42: Market opportunity by Type ($ million)
          • Exhibit 43: Data Table on Market opportunity by Type ($ million)

        7 Market Segmentation by Product

        • 7.1 Market segments
          • Exhibit 44: Chart on Product - Market share 2023-2028 (%)
          • Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
        • 7.2 Comparison by Product
          • Exhibit 46: Chart on Comparison by Product
          • Exhibit 47: Data Table on Comparison by Product
        • 7.3 Pharmaceuticals - Market size and forecast 2023-2028
          • Exhibit 48: Chart on Pharmaceuticals - Market size and forecast 2023-2028 ($ million)
          • Exhibit 49: Data Table on Pharmaceuticals - Market size and forecast 2023-2028 ($ million)
          • Exhibit 50: Chart on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
          • Exhibit 51: Data Table on Pharmaceuticals - Year-over-year growth 2023-2028 (%)
        • 7.4 Feed additives - Market size and forecast 2023-2028
          • Exhibit 52: Chart on Feed additives - Market size and forecast 2023-2028 ($ million)
          • Exhibit 53: Data Table on Feed additives - Market size and forecast 2023-2028 ($ million)
          • Exhibit 54: Chart on Feed additives - Year-over-year growth 2023-2028 (%)
          • Exhibit 55: Data Table on Feed additives - Year-over-year growth 2023-2028 (%)
        • 7.5 Vaccines - Market size and forecast 2023-2028
          • Exhibit 56: Chart on Vaccines - Market size and forecast 2023-2028 ($ million)
          • Exhibit 57: Data Table on Vaccines - Market size and forecast 2023-2028 ($ million)
          • Exhibit 58: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
          • Exhibit 59: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
        • 7.6 Others - Market size and forecast 2023-2028
          • Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
          • Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
          • Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
          • Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
        • 7.7 Market opportunity by Product
          • Exhibit 64: Market opportunity by Product ($ million)
          • Exhibit 65: Data Table on Market opportunity by Product ($ million)

        8 Customer Landscape

        • 8.1 Customer landscape overview
          • Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

        9 Geographic Landscape

        • 9.1 Geographic segmentation
          • Exhibit 67: Chart on Market share by geography 2023-2028 (%)
          • Exhibit 68: Data Table on Market share by geography 2023-2028 (%)
        • 9.2 Geographic comparison
          • Exhibit 69: Chart on Geographic comparison
          • Exhibit 70: Data Table on Geographic comparison
        • 9.3 North America - Market size and forecast 2023-2028
          • Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
          • Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
          • Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
          • Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
        • 9.4 Europe - Market size and forecast 2023-2028
          • Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
          • Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
          • Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
          • Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
        • 9.5 Asia - Market size and forecast 2023-2028
          • Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ million)
          • Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
          • Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
          • Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
        • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
          • Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
          • Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
          • Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
          • Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
        • 9.7 US - Market size and forecast 2023-2028
          • Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
          • Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
          • Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
          • Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
        • 9.8 France - Market size and forecast 2023-2028
          • Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ million)
          • Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ million)
          • Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
          • Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
        • 9.9 India - Market size and forecast 2023-2028
          • Exhibit 95: Chart on India - Market size and forecast 2023-2028 ($ million)
          • Exhibit 96: Data Table on India - Market size and forecast 2023-2028 ($ million)
          • Exhibit 97: Chart on India - Year-over-year growth 2023-2028 (%)
          • Exhibit 98: Data Table on India - Year-over-year growth 2023-2028 (%)
        • 9.10 Germany - Market size and forecast 2023-2028
          • Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
          • Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
          • Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
          • Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
        • 9.11 China - Market size and forecast 2023-2028
          • Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ million)
          • Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ million)
          • Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
          • Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
        • 9.12 Market opportunity by geography
          • Exhibit 107: Market opportunity by geography ($ million)
          • Exhibit 108: Data Tables on Market opportunity by geography ($ million)

        10 Drivers, Challenges, and Trends

        • 10.1 Market drivers
          • 10.2 Market challenges
            • 10.3 Impact of drivers and challenges
              • Exhibit 109: Impact of drivers and challenges in 2023 and 2028
            • 10.4 Market trends

              11 Vendor Landscape

              • 11.1 Overview
                • 11.2 Vendor landscape
                  • Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
                • 11.3 Landscape disruption
                  • Exhibit 111: Overview on factors of disruption
                • 11.4 Industry risks
                  • Exhibit 112: Impact of key risks on business

                12 Vendor Analysis

                • 12.1 Vendors covered
                  • Exhibit 113: Vendors covered
                • 12.2 Market positioning of vendors
                  • Exhibit 114: Matrix on vendor position and classification
                • 12.3 Biozyme Inc.
                  • Exhibit 115: Biozyme Inc. - Overview
                  • Exhibit 116: Biozyme Inc. - Product / Service
                  • Exhibit 117: Biozyme Inc. - Key offerings
                • 12.4 Boehringer Ingelheim International GmbH
                  • Exhibit 118: Boehringer Ingelheim International GmbH - Overview
                  • Exhibit 119: Boehringer Ingelheim International GmbH - Business segments
                  • Exhibit 120: Boehringer Ingelheim International GmbH - Key news
                  • Exhibit 121: Boehringer Ingelheim International GmbH - Key offerings
                  • Exhibit 122: Boehringer Ingelheim International GmbH - Segment focus
                • 12.5 Ceva Sante Animale
                  • Exhibit 123: Ceva Sante Animale - Overview
                  • Exhibit 124: Ceva Sante Animale - Product / Service
                  • Exhibit 125: Ceva Sante Animale - Key offerings
                • 12.6 Elanco Animal Health Inc.
                  • Exhibit 126: Elanco Animal Health Inc. - Overview
                  • Exhibit 127: Elanco Animal Health Inc. - Product / Service
                  • Exhibit 128: Elanco Animal Health Inc. - Key offerings
                • 12.7 IDEXX Laboratories Inc.
                  • Exhibit 129: IDEXX Laboratories Inc. - Overview
                  • Exhibit 130: IDEXX Laboratories Inc. - Business segments
                  • Exhibit 131: IDEXX Laboratories Inc. - Key news
                  • Exhibit 132: IDEXX Laboratories Inc. - Key offerings
                  • Exhibit 133: IDEXX Laboratories Inc. - Segment focus
                • 12.8 ImmuCell Corp.
                  • Exhibit 134: ImmuCell Corp. - Overview
                  • Exhibit 135: ImmuCell Corp. - Business segments
                  • Exhibit 136: ImmuCell Corp. - Key offerings
                  • Exhibit 137: ImmuCell Corp. - Segment focus
                • 12.9 Innovative Diagnostics
                  • Exhibit 138: Innovative Diagnostics - Overview
                  • Exhibit 139: Innovative Diagnostics - Product / Service
                  • Exhibit 140: Innovative Diagnostics - Key offerings
                • 12.10 Kyoritsuseiyaku Corp.
                  • Exhibit 141: Kyoritsuseiyaku Corp. - Overview
                  • Exhibit 142: Kyoritsuseiyaku Corp. - Product / Service
                  • Exhibit 143: Kyoritsuseiyaku Corp. - Key offerings
                • 12.11 Merck and Co. Inc.
                  • Exhibit 144: Merck and Co. Inc. - Overview
                  • Exhibit 145: Merck and Co. Inc. - Business segments
                  • Exhibit 146: Merck and Co. Inc. - Key news
                  • Exhibit 147: Merck and Co. Inc. - Key offerings
                  • Exhibit 148: Merck and Co. Inc. - Segment focus
                • 12.12 Norbrook Laboratories Ltd.
                  • Exhibit 149: Norbrook Laboratories Ltd. - Overview
                  • Exhibit 150: Norbrook Laboratories Ltd. - Product / Service
                  • Exhibit 151: Norbrook Laboratories Ltd. - Key offerings
                • 12.13 Phibro Animal Health Corp.
                  • Exhibit 152: Phibro Animal Health Corp. - Overview
                  • Exhibit 153: Phibro Animal Health Corp. - Business segments
                  • Exhibit 154: Phibro Animal Health Corp. - Key offerings
                  • Exhibit 155: Phibro Animal Health Corp. - Segment focus
                • 12.14 Thermo Fisher Scientific Inc.
                  • Exhibit 156: Thermo Fisher Scientific Inc. - Overview
                  • Exhibit 157: Thermo Fisher Scientific Inc. - Business segments
                  • Exhibit 158: Thermo Fisher Scientific Inc. - Key news
                  • Exhibit 159: Thermo Fisher Scientific Inc. - Key offerings
                  • Exhibit 160: Thermo Fisher Scientific Inc. - Segment focus
                • 12.15 Vetoquinol SA
                  • Exhibit 161: Vetoquinol SA - Overview
                  • Exhibit 162: Vetoquinol SA - Business segments
                  • Exhibit 163: Vetoquinol SA - Key news
                  • Exhibit 164: Vetoquinol SA - Key offerings
                  • Exhibit 165: Vetoquinol SA - Segment focus
                • 12.16 Virbac Group
                  • Exhibit 166: Virbac Group - Overview
                  • Exhibit 167: Virbac Group - Business segments
                  • Exhibit 168: Virbac Group - Key news
                  • Exhibit 169: Virbac Group - Key offerings
                  • Exhibit 170: Virbac Group - Segment focus
                • 12.17 Zoetis Inc.
                  • Exhibit 171: Zoetis Inc. - Overview
                  • Exhibit 172: Zoetis Inc. - Business segments
                  • Exhibit 173: Zoetis Inc. - Key news
                  • Exhibit 174: Zoetis Inc. - Key offerings
                  • Exhibit 175: Zoetis Inc. - Segment focus

                13 Appendix

                • 13.1 Scope of the report
                  • 13.2 Inclusions and exclusions checklist
                    • Exhibit 176: Inclusions checklist
                    • Exhibit 177: Exclusions checklist
                  • 13.3 Currency conversion rates for US$
                    • Exhibit 178: Currency conversion rates for US$
                  • 13.4 Research methodology
                    • Exhibit 179: Research methodology
                    • Exhibit 180: Validation techniques employed for market sizing
                    • Exhibit 181: Information sources
                  • 13.5 List of abbreviations
                    • Exhibit 182: List of abbreviations

                  Research Methodology

                  Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

                  INFORMATION SOURCES

                  Primary sources

                  • Manufacturers and suppliers
                  • Channel partners
                  • Industry experts
                  • Strategic decision makers

                  Secondary sources

                  • Industry journals and periodicals
                  • Government data
                  • Financial reports of key industry players
                  • Historical data
                  • Press releases

                  DATA ANALYSIS

                  Data Synthesis

                  • Collation of data
                  • Estimation of key figures
                  • Analysis of derived insights

                  Data Validation

                  • Triangulation with data models
                  • Reference against proprietary databases
                  • Corroboration with industry experts

                  REPORT WRITING

                  Qualitative

                  • Market drivers
                  • Market challenges
                  • Market trends
                  • Five forces analysis

                  Quantitative

                  • Market size and forecast
                  • Market segmentation
                  • Geographical insights
                  • Competitive landscape

                  Interested in this report?

                  Get your sample now to see our research methodology and insights!

                  Download Now

                  Frequently Asked Questions

                  Cattle Healthcare market growth will increase by $ 4.47 bn during 2024-2028.

                  The Cattle Healthcare market is expected to grow at a CAGR of 8.91% during 2024-2028.

                  Cattle Healthcare market is segmented by Type( Beef cattle, Dairy cattle) Product( Pharmaceuticals, Feed additives, Vaccines, Others)

                  Biozyme Inc., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Elanco Animal Health Inc., IDEXX Laboratories Inc., ImmuCell Corp., Indian Immunologicals Ltd., Innovative Diagnostics, International Health Care Ltd., Kyoritsuseiyaku Corp., Merck and Co. Inc., Norbrook Laboratories Ltd., Phibro Animal Health Corp., Thermo Fisher Scientific Inc., Vamso Biotec Pvt. Ltd., Vetoquinol SA, Virbac Group, Zenex Animal Health India Private Ltd., Zoetis Inc., Zovix Pharmaceuticals are a few of the key vendors in the Cattle Healthcare market.

                  North America will register the highest growth rate of 37% among the other regions. Therefore, the Cattle Healthcare market in North America is expected to garner significant business opportunities for the vendors during the forecast period.

                  US, France, Germany, India, China

                  • Rising burden of cattle diseasesThe rising burden of cattle diseases is a significant driver behind the growth of the global cattle healthcare market. Cattle are susceptible to a wide range of diseases is the driving factor this market.
                  • including respiratory infections is the driving factor this market.
                  • gastrointestinal disorders is the driving factor this market.
                  • reproductive issues is the driving factor this market.
                  • and parasitic infestations is the driving factor this market.
                  • among others. These diseases not only pose health risks to individual animals but also have economic implications for cattle farmers is the driving factor this market.
                  • including reduced productivity is the driving factor this market.
                  • increased mortality rates is the driving factor this market.
                  • and treatment costs. As global populations continue to grow is the driving factor this market.
                  • the demand for beef and dairy products is increasing is the driving factor this market.
                  • leading to the expansion of cattle farming operations worldwide. However is the driving factor this market.
                  • this growth is accompanied by a greater risk of disease outbreaks is the driving factor this market.
                  • particularly in intensively managed production systems where cattle are kept in high-density environments. Factors such as poor sanitation is the driving factor this market.
                  • inadequate nutrition is the driving factor this market.
                  • and stress can exacerbate disease susceptibility among cattle herds is the driving factor this market.
                  • further increasing the burden of diseases. In response to these challenges is the driving factor this market.
                  • cattle farmers are increasingly investing in healthcare solutions to prevent is the driving factor this market.
                  • diagnose is the driving factor this market.
                  • and treat diseases in their herds. This includes the adoption of vaccination programs to protect against common pathogens is the driving factor this market.
                  • deworming protocols to control parasites is the driving factor this market.
                  • and implementing biosecurity measures to prevent disease transmission. Additionally is the driving factor this market.
                  • advancements in veterinary medicine and technology have made it easier for farmers to monitor the health status of their herds and implement proactive disease management strategies. Therefore is the driving factor this market.
                  • the rising burden of cattle diseases is expected to grow during the forecast period and thereby will drive the growth of the global cattle healthcare market during the forecast period. is the driving factor this market.

                  The Cattle Healthcare market vendors should focus on grabbing business opportunities from the Beef cattle segment as it accounted for the largest market share in the base year.